Literature DB >> 18499284

Long-term prognostic value of heart-rate recovery after treadmill testing in patients with diabetes mellitus.

Panagiotis Georgoulias1, Nikolaos Demakopoulos, Varvara Valotassiou, Alexandros Orfanakis, Alexia Zaganides, Ioannis Tsougos, Ioannis Fezoulidis.   

Abstract

BACKGROUND: Heart-rate recovery (HRR) is considered to be an independent predictor of cardiac and all-cause mortality. We examined the long-term prognostic value of HRR in patients suffering from diabetes mellitus.
METHODS: In this study, we included 258 consecutive patients. Patients whose HRR value or myocardial perfusion imaging could have been influenced by factors other than myocardial ischaemia, were excluded. The value of HRR was defined as the decrease in the heart-rate from peak exercise to 1 min after the termination of the exercise. All patients underwent SPECT myocardial perfusion imaging combined with exercise testing. Cardiovascular death and non-fatal myocardial infarction were considered as hard cardiac events, while late revascularization procedures as soft events. Cox proportional-hazard models were applied to evaluate the association between HRR and the investigated outcome.
RESULTS: During the follow-up period (30.8+/-6.9 months), hard cardiac events occurred in 21 (8%) patients (15 with abnormal HRR value, p<0.001), while 35 (14%) patients underwent revascularization (31 with abnormal HRR value, p<0.001). Considering it as a continuous variable, HRR was a strong predictor for both hard cardiac (coefficient=-0.41, SE=0.052, p<0.001) and soft cardiac events (coefficient=-0.63, SE=0.058, p<0.001). After adjustments were made for potential confounders, including scintigraphic variables, abnormal HRR remained an independent predictor for hard and soft cardiac events (p<0.001).
CONCLUSION: Our results suggest that among patients with diabetes, a decreased HRR is a significant independent predictor of hard and soft cardiac events.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499284     DOI: 10.1016/j.ijcard.2008.01.036

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Heart-rate recovery as a clinical marker of cardiovascular autonomic dysfunction in diabetic patients.

Authors:  Panagiotis Georgoulias; Varvara Valotassiou; Ioannis Tsougos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-19       Impact factor: 9.236

Review 2.  Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus.

Authors:  Neal B Patel; Gary J Balady
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

3.  Heart rate recovery is impaired after maximal exercise testing in children with sickle cell anemia.

Authors:  Anthony M Alvarado; Kendra M Ward; Devin S Muntz; Alexis A Thompson; Mark Rodeghier; Bo Fernhall; Robert I Liem
Journal:  J Pediatr       Date:  2014-12-02       Impact factor: 4.406

4.  Chronotropic Competence Indices Extracted from Wearable Sensors for Cardiovascular Diseases Management.

Authors:  Jiankang Wu; Jianan Li; Andrew Seely; Yi Zhu; Sisi Huang; Xiaoqin Wang; Lei Zhao; Hongliang Wang; Herry Christophe
Journal:  Sensors (Basel)       Date:  2017-10-25       Impact factor: 3.576

5.  Exercise training on chronotropic response and exercise capacity in patients with type 2 diabetes mellitus.

Authors:  Li Jin; Gao Min; Chen Wei; He Min; Zhou Jie
Journal:  Exp Ther Med       Date:  2017-01-24       Impact factor: 2.447

6.  Prevalence and predictors of abnormal cardiovascular responses to exercise testing among individuals with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) study.

Authors:  Jeffrey M Curtis; Edward S Horton; Judy Bahnson; Edward W Gregg; John M Jakicic; Judith G Regensteiner; Paul M Ribisl; Judith E Soberman; Kerry J Stewart; Mark A Espeland
Journal:  Diabetes Care       Date:  2010-01-07       Impact factor: 19.112

7.  Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.

Authors:  Kai-Hang Yiu; Kui-Kai Lau; Chun-Ting Zhao; Yap-Hang Chan; Yan Chen; Zhe Zhen; Arthur Wong; Chu-Pak Lau; Hung-Fat Tse
Journal:  Cardiovasc Diabetol       Date:  2014-03-25       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.